Key EU legislator lets IVD industry off lightly
This article was originally published in SRA
Executive Summary
The in vitro diagnostics industry has escaped the threat of having its products regulated under a pharma-like pre-market authorisation system in the EU - or so it would appear from a draft report by the European Parliament committee working on the European Commission's proposed IVD regulation (IVDR)1.